ChemNet > CAS > 179324-69-7 Bortezomib
179324-69-7 Bortezomib
| Nom |
Bortezomib |
| Nom anglais |
Bortezomib; VELCADE; dpba; [(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid; VELCADE(BORTEZOMIB); Boronic acid, B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-; Bortezomib for research; N-[(1S)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-D-phenylalaninamide; N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide; Bortizomib |
| Formule moléculaire |
C19H25BN4O4 |
| Poids Moléculaire |
384.2372 |
| InChI |
InChI=1/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1 |
| Numéro de registre CAS |
179324-69-7 |
| Structure moléculaire |
|
| Densité |
1.214g/cm3 |
| Point de fusion |
122-124℃ |
| Indice de réfraction |
1.564 |
| Les symboles de danger |
|
| Codes des risques |
|
| Description de sécurité |
|
|
